Señales en vivo de AVDL | Maximiza tus Ganancias con Getagraph.com

VENDER 109746 min ago

@ $14.22

Emitido: 14 feb 2024 @ 09:32

Retorno: 28.59%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: -0.21 %

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 15:39):

Stats
Volumen de hoy	594 793
Volumen promedio	1.19M
Capitalización de mercado	1.85B
EPS	$0 ( 2024-03-04 )
Próxima fecha de ganancias	( $-0.250 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.14
ATR14	$0.0170 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-20	Kim Richard J	Buy	147 000	Stock Option (Right to Buy)
2024-02-20	Mchugh Thomas S	Buy	157 500	Stock Option (Right to Buy)
2024-02-20	Divis Gregory J	Buy	600 000	Stock Option (Right to Buy)
2024-01-16	Mchugh Thomas S	Buy	2 000	ADSs
2023-12-28	Mccamish Mark Anthony	Sell	75 000	ADSs

INSIDER POWER
81.01
Last 94 transactions
Buy: 6 417 800 \| Sell: 317 647

Volumen Correlación

Largo: -0.12 (neutral)

Corto: -0.95 (very strong negative)

Signal:(49.35) Neutral

Avadel Pharmaceuticals Correlación

10 Correlaciones Más Positivas
HSKA	0.968
ATRS	0.958
LIQT	0.946
ISEE	0.944
XLRN	0.94
BLU	0.936
OVID	0.934
CFIV	0.933
MNST	0.93
LABP	0.93

10 Correlaciones Más Negativas
PEAR	-0.951
MTEX	-0.946
VYNT	-0.944
NTGR	-0.939
CFBK	-0.937
HMST	-0.931
VORB	-0.93
INFN	-0.929
AUB	-0.927
EVBG	-0.925

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avadel Pharmaceuticals Correlación - Moneda/Commodity

-0.68
( moderate negative )

-0.59
( weak negative )

0.46
( neutral )

-0.48
( neutral )

-0.34
( neutral )

0.28
( neutral )

Avadel Pharmaceuticals Finanzas

Annual	2023
Ingresos:	$27.96M
Beneficio Bruto:	$25.35M (90.66 %)
EPS:	$-2.00

FY	2023
Ingresos:	$27.96M
Beneficio Bruto:	$25.35M (90.66 %)
EPS:	$-2.00

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-1.49M (0.00 %)
EPS:	$-2.29

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.320

Financial Reports:

No articles found.

Avadel Pharmaceuticals

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Actualizaciones en tiempo real para Avadel Pharmaceuticals [AVDL]

Upcoming Earnings Alert